Coexistence of congenital left ventricular aneurysm and prominent left ventricular trabeculation in a patient with LDB3 mutation: a case report

Shengshuai Shan, Xiaoxiao He, Lin He, Min Wang, Chengyun LiuJournal of Medical Case Reports 2017 · DOI

Abstract

Our finding indicates that the phenotypic expression of two heart conditions, congenital left ventricular aneurysm and prominent left ventricular trabeculation, although rare, can occur simultaneously with LDB3 gene mutation. Congenital left ventricular aneurysm and prominent left ventricular trabeculation may share the same genetic background.

Introduction

The development of the human heart is a complex orchestration of cellular migration and structural patterning. When this process is disrupted, it results in various congenital malformations. Two such rare anomalies are congenital left ventricular aneurysm (LVA) and prominent ventricular trabeculation.

Congenital LVA is an extremely rare "out-pouching" of the heart wall, typically characterized as an akinetic or dyskinetic structure. Its pathogenesis remains poorly understood, and until recently, no specific genetic markers had been definitively identified. Prominent trabeculation, on the other hand, involves an exaggeration of the muscular meshwork inside the heart. While some degree of trabeculation is normal, excessive amounts are often linked to genetic cardiomyopathies like Left Ventricular Non-Compaction (LVNC). This case report investigates a 30-year-old patient exhibiting both conditions, aiming to identify a shared molecular link that explains these developmental defects.

Case Presentation and Diagnostic Evaluation

A 30-year-old Asian male presented with structural cardiac anomalies. To determine the etiology and rule out acquired causes such as myocardial infarction, systemic lupus erythematosus (SLE), or myocarditis, a multi-modal diagnostic approach was employed.

Clinical screening included physical examinations and serological tests for myocardial injury markers, such as troponin, and virological tests. Advanced imaging was pivotal in characterizing the structural defects:

  • Coronary Computed Tomography Angiography (CTA): Used to ensure the aneurysm was not a secondary result of coronary artery disease (stenosis).
  • Contrast Echocardiography & Cardiac Magnetic Resonance (CMR): These provided high-resolution visualization of the heart's internal structure, confirming the coexistence of an apical aneurysm with a wide connection to the left ventricle and a prominent trabecular meshwork.
Figure 4: Electrocardiogram (A) and 3D cardiac reconstructions (B) illustrating the patient's clinical and structural presentation.

Genetic Analysis and Key Findings

Genomic analysis using high-throughput sequencing was performed to screen for mutations in known cardiomyopathy-related genes. The team identified a novel heterozygous missense mutation in the LDB3 gene (c.C793>T; p.Arg265Cys). This gene encodes the Z-band alternatively spliced PDZ motif (ZASP) protein, which acts as a critical "glue" in the heart's Z-discs, maintaining the structural integrity of striated muscle.

The specific mutation found was not present in major genomic databases, such as the Human Gene Mutation Database (HGMD) or the Single Nucleotide Polymorphism database (dbSNP), marking it as a novel discovery. Multiple in silico pathogenicity prediction tools (MutationTaster, PolyPhen-2, SIFT) predicted the mutation to be pathogenic, as it involves a highly conserved amino acid residue essential for protein function. These findings suggest that LVA and prominent trabeculation may be different phenotypic expressions of the same underlying structural failure during embryonic development, likely occurring around the fourth week of gestation.

Discussion and Future Directions

This case provides the first evidence linking LDB3 mutations to the simultaneous occurrence of LVA and prominent trabeculation. By meticulously ruling out acquired conditions, the authors strengthened the argument that these anomalies are truly congenital and genetically driven by Z-disc protein dysfunction.

While the patient remained clinically stable and asymptomatic during a 3-month follow-up, the presence of LVA carries significant risks, including ventricular rupture or sudden cardiac death. The primary limitation of this study is the single-patient sample size (n=1). Future research should focus on:

  • Functional Studies: Performing in vitro or animal model studies to observe how the p.Arg265Cys mutation disrupts Z-disc assembly during cardiogenesis.
  • Broader Screening: Screening other patients with congenital LVA for LDB3 or other Z-disc protein mutations to confirm if this is a consistent genetic driver.
  • Long-term Monitoring: Gathering longitudinal data to guide clinical management for patients with this specific genetic profile.

Summary updated

Abstract

Our finding indicates that the phenotypic expression of two heart conditions, congenital left ventricular aneurysm and prominent left ventricular trabeculation, although rare, can occur simultaneously with LDB3 gene mutation. Congenital left ventricular aneurysm and prominent left ventricular trabeculation may share the same genetic background.
BibTeX
@article{shan2017coexistence,
  author = {Shengshuai Shan and Xiaoxiao He and Lin He and Min Wang and Chengyun Liu},
  title = {{Coexistence of congenital left ventricular aneurysm and prominent left ventricular trabeculation in a patient with LDB3 mutation: a case report}},
  journal = {Journal of Medical Case Reports},
  year = {2017},
  doi = {10.1186/s13256-017-1405-1},
}
Figure